Cite Filings / DFTX / 0000950170-22-016893

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Definium Therapeutics, Inc. Filed 2022-08-11 Acc 0000950170-22-016893

Documents 1

10-Q Quarterly Report , mnmd-20220630.htm

Around this filing

2022-11-10 10-Q Quarterly Report
2022-08-15 4 Director acquired 89,286 shares (grant or award)
2022-08-15 4 Director acquired 89,286 shares (grant or award)
2022-08-15 3 Initial Statement of Ownership
2022-08-11 10-Q Quarterly Report
2022-08-11 8-K Results of operations · Executive or director change
2022-05-16 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading mnmd-20220630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…